Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Revolution Medicines, Inc.

NASDAQ: RVMD · Life Sciences · 14 alerts · CIK 1628171

Share price
$166.87Close, Nov 16
Market cap
$36.1B
Shares outstanding
216.29MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Revolution Medicines, Inc. filings on SEC EDGAR ↗

6:00 PM ET Form 4
Insider Selling

Revolution Medicines CFO Jack Anders Sells $6.72M of Stock

Jack Anders, CFO, sold 35,750 shares of Revolution Medicines, Inc. at $181.04 to $192.84 a share (average $188.10) in 11 transactions, worth $6.72M in total on Nov 11, 2026. Shares held after the trade: 119,216 (-7.7%).

Value
$6.72M
Shares
35,750
Average price
$188.10
Role
CFO
Holding change
-7.7%
Trade date
Nov 11, 2026
6:00 PM ET Form 4
Insider Selling

Revolution Medicines Insider Anthony Mancini Sells $432K of Stock

Anthony Mancini sold 2,310 shares of Revolution Medicines, Inc. at $186.99 a share, worth $432K in total on Oct 26, 2026. Shares held after the trade: 39,765 (-5.5%).

Value
$432K
Shares
2,310
Price
$186.99
Holding change
-5.5%
Trade date
Oct 26, 2026
6:00 PM ET Form 4
Insider Selling

Revolution Medicines Chief Development Officer Alan B. Sandler Sells $1.28M of Stock

Alan B. Sandler, Chief Development Officer, sold 6,309 shares of Revolution Medicines, Inc. at $200.82 to $204.72 a share (average $202.14) in 5 transactions, worth $1.28M in total on Sep 29, 2026. Shares held after the trade: 52,559 (-0.6%).

Value
$1.28M
Shares
6,309
Average price
$202.14
Role
Chief Development Officer
Holding change
-0.6%
Trade date
Sep 29, 2026
6:00 PM ET Form 4
Insider Selling

Revolution Medicines Director Elizabeth M. Anderson Sells $1.96M of Stock

Elizabeth M. Anderson, Director, sold 10,143 shares of Revolution Medicines, Inc. at $191.85 to $195.15 a share (average $193.04) in 5 transactions, worth $1.96M in total on Sep 22, 2026. Shares held after the trade: 4,333 (-2.3%).

Value
$1.96M
Shares
10,143
Average price
$193.04
Role
Director
Holding change
-2.3%
Trade date
Sep 22, 2026
6:06 PM ET Form 4
Insider Selling

Revolution Medicines Chief Development Officer Alan B. Sandler Sells $67K of Stock

Alan B. Sandler, Chief Development Officer, sold 336 shares of Revolution Medicines, Inc. at $199.30 a share, worth $67K in total on Sep 16, 2026. Shares held after the trade: 52,868 (-0.6%).

Value
$67K
Shares
336
Price
$199.30
Role
Chief Development Officer
Holding change
-0.6%
Trade date
Sep 16, 2026
6:05 PM ET Form 4
Insider Selling

Revolution Medicines Insider Anthony Mancini Sells $348K of Stock

Anthony Mancini sold 1,747 shares of Revolution Medicines, Inc. at $199.30 a share, worth $348K in total on Sep 16, 2026. Shares held after the trade: 42,116 (-4.0%).

Value
$348K
Shares
1,747
Price
$199.30
Holding change
-4.0%
Trade date
Sep 16, 2026
6:04 PM ET Form 4
Insider Selling

Revolution Medicines Insider Stephen Michael Kelsey Sells $1.11M of Stock

Stephen Michael Kelsey sold 5,569 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $1.11M in total on Sep 16, 2026. Shares held after the trade: 286,307 (-1.9%).

Value
$1.11M
Shares
5,569
Average price
$199.24
Holding change
-1.9%
Trade date
Sep 16, 2026
6:03 PM ET Form 4
Insider Selling

Revolution Medicines COO Margaret A. Horn Sells $990K of Stock

Margaret A. Horn, COO, sold 4,967 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $990K in total on Sep 16, 2026. Shares held after the trade: 149,680 (-3.2%).

Value
$990K
Shares
4,967
Average price
$199.24
Role
COO
Holding change
-3.2%
Trade date
Sep 16, 2026
6:02 PM ET Form 4
Insider Selling

Revolution Medicines Insider Mark A. Goldsmith Sells $2.79M of Stock

Mark A. Goldsmith sold 13,988 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $2.79M in total on Sep 16, 2026. Shares held after the trade: 253,342 (-5.2%).

Value
$2.79M
Shares
13,988
Average price
$199.24
Holding change
-5.2%
Trade date
Sep 16, 2026
6:01 PM ET Form 4
Insider Selling

Revolution Medicines SVP & General Counsel Jeff Cislini Sells $671K of Stock

Jeff Cislini, SVP & General Counsel, sold 3,366 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $671K in total on Sep 16, 2026. Shares held after the trade: 52,541 (-5.9%).

Value
$671K
Shares
3,366
Average price
$199.24
Role
SVP & General Counsel
Holding change
-5.9%
Trade date
Sep 16, 2026
6:00 PM ET Form 4
Insider Selling

Revolution Medicines CFO Jack Anders Sells $808K of Stock

Jack Anders, CFO, sold 4,053 shares of Revolution Medicines, Inc. at $195.00 to $199.30 a share (average $199.24) in 2 transactions, worth $808K in total on Sep 16, 2026. Shares held after the trade: 119,216 (-3.2%).

Value
$808K
Shares
4,053
Average price
$199.24
Role
CFO
Holding change
-3.2%
Trade date
Sep 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.